The LEAP checklist for laboratory evaluation and analytical performance characteristics reporting of clinical measurement procedures. [PDF]
Loh TP +7 more
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Comparison of 3D printed and conventional denture base materials in terms of durability and performance characteristics. [PDF]
Öztürk Z, Tosun B.
europepmc +1 more source
Impact of the Anatomical Accelerometer Placement on Vertical Jump Performance Characteristics. [PDF]
Cabarkapa DV +3 more
europepmc +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source
Performance characteristics and potential public health impact of improved pre-erythrocytic malaria vaccines targeting childhood burden. [PDF]
Malinga J +10 more
europepmc +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source
Future development directions of high-temperature strain gauges: a comprehensive review of structure and performance characteristics. [PDF]
Liu X +9 more
europepmc +1 more source
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard +5 more
wiley +1 more source
Performance characteristics of three <i>Brucella canis</i> serological assays in the United States. [PDF]
LeCuyer TE +25 more
europepmc +1 more source

